— Know what they know.
Not Investment Advice

ICVX NASDAQ

Icosavax, Inc.
1W: +0.0% 1M: +0.1% 3M: +47.5% 1Y: +87.2%
$15.31
Last traded 2024-02-29 — delisted
NASDAQ · Healthcare · Biotechnology · $769.0M mcap · 29M float · 4.23% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$582K -92.5% ▼
Gross Profit
-$1M -116.3% ▼
Operating Income
-$95M -44.3% ▼
Net Income
-$88M -30.1% ▼
EPS (Diluted)
$-2.23 +41.0% ▲
EBITDA
-$94M -46.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022
Revenue$0$2M$8M$582K
YoY Growth+0.0%+0.0%+382.8%-92.5%
Cost of Revenue$4M$18M$82K$2M
Gross Profit-$4M-$16M$8M-$1M
Gross Margin—-993.3%98.9%-216.7%
R&D Expenses$4M$18M$39M$65M
SG&A Expenses$1M$3M$35M$30M
Operating Expenses$5M$19M$66M$95M
Operating Income-$5M-$19M-$66M-$95M
Operating Margin—-1157.8%-844.2%-16333.0%
Interest Expense$0$331K$151K$0
Income Before Tax-$5M-$19M-$67M-$92M
Tax Expense-$101K$331K$1M-$3M
Net Income-$5M-$19M-$68M-$88M
Net Margin—-1187.2%-871.6%-15199.0%
EPS (Diluted)$-0.51$-6.67$-3.78$-2.23
EBITDA-$5M-$19M-$65M-$94M
Shares Outstanding10M3M18M40M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms